Venous Devices Come into Their Own


Diseases of the deep veins can be deadly, but this clinical segment has been an innovation backwater. Things are changing: the first venous stents were approved in 2019, and several start-ups are addressing unmet clinical needs with devices purposely built for veins, not borrowed from the arterial side of the anatomy.

Not so very long ago, a medical device entrepreneur attended a clinical conference on venous disease to learn about the field, and was surprised by the decidedly low-tech nature of current therapies. “It looked more like JC Penney’s than a clinical conference,” he said, “lots of mannequin legs wearing socks.”

This article is restricted to subscribers only.

To continue reading, select one of the options below:

Existing Subscriber?

Sign In to continue reading.

Need Multi-User Access?

Gain access for your entire organization.

Get Quote Check to see if your company already has access

Subscribe to MedTech Strategist:

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Subscribe to MedTech Strategist
Subscribe to ELITE Strategist

Become an ELITE Strategist and unlock access to both MedTech Strategist and MTS Market Pathways.

Subscribe to Elite


We're here to help! Please contact us at: